Palmer Shannon, Chen Ashley, Dennison Taylor, Czech Cameron, Auten Jessica, Buhlinger Kaitlyn, Muluneh Benyam
Department of Pharmacy, University of North Carolina Medical Center, Chapel Hill, NC 27514, USA.
UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC 27514, USA.
Pharmacy (Basel). 2021 Jul 23;9(3):130. doi: 10.3390/pharmacy9030130.
Oncology clinical pharmacists are uniquely positioned to make interventions to impact the knowledge, attitudes, and practices of clinicians as well as patient activation and engagement. To accomplish this goal, pharmacists can target health system-related, provider-related, and patient-related factors to enhance patient-centered care and drive behavioral health changes. Interventions that pharmacists must tackle include educating team members and patients on the medication acquisition process, communicating urgency of treatment, optimizing workflows, facilitating guideline recommendations, preventing, and managing treatment toxicities, and promoting patient self-advocacy through education and shared decision-making. As crucial members of the healthcare team, oncology pharmacists can simplify highly complex treatment regimens to facilitate and optimize patients' ownership of their care. This narrative review will focus on the example of venetoclax treatment in acute myeloid leukemia to demonstrate the impact that pharmacists provide that leads to behavioral change of patients and clinicians.
肿瘤临床药师在进行干预以影响临床医生的知识、态度和实践以及患者的积极性和参与度方面具有独特的地位。为实现这一目标，药师可以针对与卫生系统、医疗服务提供者和患者相关的因素，以加强以患者为中心的护理并推动行为健康改变。药师必须应对的干预措施包括就药物获取过程对团队成员和患者进行教育、传达治疗的紧迫性、优化工作流程、促进指南建议的实施、预防和管理治疗毒性，以及通过教育和共同决策促进患者自我维权。作为医疗团队的关键成员，肿瘤药师可以简化高度复杂的治疗方案，以促进和优化患者对自身护理的掌控。本叙述性综述将聚焦于维奈克拉治疗急性髓系白血病的实例，以展示药师所提供的导致患者和临床医生行为改变的影响。
